Two 5‐oxa‐2,6‐diazaspiro[3.4]octan‐1‐one derivatives from the [3+2] cyclo­addition of methylenelactams with nitrones

The two title 5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one adducts, 7‐benzoyl‐2‐(4‐methoxy­phenyl)‐6‐phenyl‐5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one, C₂₅H₂₂N₂O₄, (III), and 6‐tert‐butyl‐2‐(4‐methyl­phenyl)‐7‐phenyl‐5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one, C₂₂H₂₆N₂O₂, (IV), were obtained from a stereospecific [3+2] 1,3‐cyclo­addition of 3‐methyl­ene azetidin‐2‐ones as dipolaro­philes with nitro­nes. The lactam ring is conjugated with the p‐­methoxy­phenyl or p‐methyl­phenyl moiety. The envelope conformations of the isoxazolidine rings in (III) and (IV) are different, leading the substituents to be pseudo‐axial in (III) and pseudo‐equatorial in (IV).     

(Z)‐2‐(3‐Methoxy­benzyl­idene)‐1‐aza­bicyclo­[2.2.2]octan‐3‐one

The crystal structure of the title compound, C₁₅H₁₇NO₂, contains two nearly identical but crystallographically independent mol­ecules, each with a double bond connecting an aza­bicyclic ring system to a 3‐methoxy­benzyl­idene moiety. The space group is triclinic P. The benzene ring is twisted by 18.44 (5) and 22.35 (4)° with respect to the plane of the double bond connected to the azabicyclic ring system for the two mol­ecules. In addition to C—H⋯π inter­actions, mol­ecules are held together in the solid state by van der Waals inter­actions.     

A 1:1 adduct of hexa­methylene­tetramine and 4‐hydroxy‐3‐methoxy­benz­aldehyde

In the title complex, C₆H₁₂N₄·C₈H₈O₃, the hexa­methyl­ene­tetramine mol­ecule accepts a single intermolecular O—H?N hydrogen bond from the hydroxy group of the 4‐hydroxy‐3‐methoxy­benz­aldehyde moiety. The non‐centrosymmetric crystal structure is built from alternating molecular sheets of 4‐hydroxy‐3‐methoxy­benz­aldehyde and hexa­methyl­ene­tetramine mol­ecules, and is stabilized by intermolecular O—H?N, C—H?O and C—H?π interactions.     

10‐Ethyl‐3‐(4‐methoxy­phenyl)‐1,2,4‐triazolo­[4′,3′:2,3]‐1,2,4‐triazino[5,6‐b]­indole

Oxidative cyclization of 5‐ethyl‐3‐(4‐methoxy­benzyl­idene)­hydrazino‐1,2,4‐triazino­[5,6‐b]­indole gave the linearly annel­ated title compound, C₁₉H₁₆N₆O. The skeleton is approx­imately planar, except for the ethyl group.     

N‐(4‐Cyano­phenyl)‐α‐(4‐methoxy­phenyl)­nitro­ne

In the crystal structure of the title compound, 4‐cyano‐N‐(4‐methoxy­benzyl­idene)­phenyl­amine N‐oxide, C₁₅H₁₂N₂O₂, the 4‐methoxy­phenyl is approximately coplanar with the nitrone moiety but significantly rotated with respect to the 4‐cyano­phenyl moiety. The extent of this rotation is significantly different for the two crystallographically independent mol­ecules of the asymmetric unit [dihedral angles of 19.4 (1) and 26.5 (1)°]. The geometry about the C=N bond is Z. The two mol­ecules are related to one another by a pseudo inversion centre.     

Tetrakis(μ‐2,3‐dimethoxybenzoato)bis[(2,2′‐bipyridine)(2,3‐dimethoxybenzoato)lanthanum(III)]

The title compound, tetrakis(μ‐2,3‐di­methoxy­benzoato)‐κ⁴O:O′;κ⁶O,O′:O′‐bis[(2,2′‐bi­pyridine‐N,N′)(2,3‐di­methoxy­benzoato‐O,O′)lanthanum(III)], [La₂(2,3‐DMOBA)₆(2,2′‐bpy)₂], where 2,3‐DMOBA is 2,3‐di­methoxy­benzoate (C₉H₉O₄) and 2,2′‐bpy is 2,2′‐bi­pyridine (C₁₀H₈N₂), is a dimer with a centre of inversion between the La atoms bridged by four carboxyl­ate ligands. The central La atom is ennea‐coordinated and has a distorted monocapped square‐antiprism geometry.     

2‐(3‐Pyridyl)‐1,3,8‐tri­aza­naphthalene,a product of the catalytic transformation of 3‐cyano­pyridine

The title compound, C₁₂H₈N₄, was obtained by thermal treatment of 3‐cyano­pyridine in the presence of magnesium phthalocyanine as catalyst. The X‐ray structure analysis, in direct contrast to molecular orbital calculations corresponding to the gas phase, shows the mol­ecule to be non‐planar in the solid state, with an interplanar angle between the pyridine and 1,3,8‐tri­aza­naphthalene rings of 13.33 (9)°. Mol­ecules related to one another by cell translation, and positioned at intervals consistent with π–π intermolecular interactions, form stacks in the b direction.     

catena‐Poly­[[tetrakis­[μ‐(3‐methoxy­phenyl)­acetato‐O:O′]­dicopper(II)]‐μ‐2‐aminopyrimidine‐N1:N3]

The structure of the title compound, [Cu₂(C₉H₉O₃)₄(C₄H₅N₃)], comprises a zigzag polymer of alternating tetrakis­(carboxyl­ato‐O:O′)­dicopper(II) and 2‐amino­pyrimidine units linked by axial Cu—N bonds, and the non‐centrosymmetric structure has four unique (3‐methoxy­phenyl)­acetate moieties.     

Two isomers of 2,4‐di­benzyl‐8‐azabicyclo­[3.2.1]­octan‐3‐ol

The crystal structures of the title compounds, 2α,4α‐di­benzyl‐3α‐tropanol (2α,4α‐di­benzyl‐8‐methyl‐8‐aza­bi­cyclo­[3.2.1]­octan‐3α‐ol), C₂₂H₂₇NO, (I), and 2α,4α‐di­benzyl‐3β‐tropanol (2α,4α‐di­benzyl‐8‐methyl‐8‐aza­bi­cyclo­[3.2.1]­octan‐3β‐ol), C₂₂H₂₇NO, (II), show that both compounds have a piperidine ring in a chair conformation and a pyrrolidine ring in an envelope conformation. Isomer (I) is asymmetric, the benzyl groups having different orientations, whereas isomer (II) is mirror symmetric, and the N and O atoms, the C atom attached to the hydroxy group, and the methyl C atom attached to the N atom lie on the mirror plane. In the crystal structures of both (I) and (II), the mol­ecules are linked together by intermolecular O—H⋯N hydrogen bonds to form chains that run parallel to the a direction in (I) and parallel to b in (II).     

(Z)‐2‐(1H‐Indol‐3‐yl­methyl­ene)‐1‐azabi­cyclo­[2.2.2]­octan‐3‐one

The title compound, C₁₆H₁₆N₂O, which contains a double bond connecting an aza­bicyclic ring system to an indol‐3‐ylmethyl­ene group, crystallizes from a solution in ethyl acetate. The geometries of the two crystallographically independent mol­ecules are nearly identical. The crystal packing of the title compound involves two types of intermolecular hydrogen bond.     

Three (E)‐2‐[(bromo­phen­yl)imino­meth­yl]‐4‐methoxy­phenols

The title compounds, (E)‐2‐[(2‐bromo­phenyl)imino­methyl]‐4‐methoxy­phenol, C₁₄H₁₂BrNO₂, (I), (E)‐2‐[(3‐bromo­phenyl)­imino­methyl]‐4‐methoxy­phenol, C₁₄H₁₂BrNO₂, (II), and (E)‐2‐[(4‐bromo­phenyl)imino­methyl]‐4‐methoxy­phenol, C₁₄H₁₂BrNO₂, (III), adopt the phenol–imine tautomeric form. In all three structures, there are strong intra­molecular O—H⋯N hydrogen bonds. Compound (I) has strong inter­molecular hydrogen bonds, while compound (III) has weak inter­molecular hydrogen bonds. In addition to these inter­molecular inter­actions, C—H⋯π inter­actions in (I) and (III), and π–π inter­actions in (I), play roles in the crystal packing. The dihedral angles between the aromatic rings are 15.34 (12), 6.1 (3) and 39.2 (14)° for (I), (II) and (III), respectively.     

2‐(6‐Bromo­pyridin‐2‐yl)‐6‐methyl‐[1,3,6,2]­diox­aza­borocane,a new stable (pyridin‐2‐yl)­boronic acid derivative

The crystal structure of the first reported non‐substituted N‐methyl­diox­aza­borocane confirms that the presence of a methyl group attached to the N atom introduces an NB bond length that is longer than that in a simple diox­aza­borocane ring. The presence of more N atoms in the vicinity of the B atom in the title compound [systematic name: 6a‐(6‐bromo­pyridin‐2‐yl)‐3a‐methyl‐2,3,4,5‐tetra­hydro‐1,6‐dioxa‐3a‐aza‐6a‐borapentalene], C₁₀H₁₄BBrN₂O₂, does not modify significantly any structural parameter in the diox­aza­borocane ring. On the other hand, a small asymmetry appears in the bond angles of the pyridine C atom next to the B atom.     

catena‐Poly­[europium(III)‐tri‐μ‐2,3‐di­methoxy­benzoato]

The title compound, [Eu(C₉H₉O₄)₃]_n or [Eu(2,3‐DMOBA)₃]_n, where 2,3‐DMOBA is 2,3‐di­methoxy­benzoate, is an infinite one‐dimensional non‐centrosymmetric coordination polymer. The unique Eu^III atom is bridged by six carboxyl­ate ligands; it is ennea‐coordinated and has a distorted tricapped trigonal prism geometry. The Eu—O distances are in the range 2.315 (3)–2.959 (5) Å.     

Di­propyl 3,6‐di­phenyl‐1,2‐di­hydro‐1,2,4,5‐tetrazine‐1,2‐di­carboxyl­ate

The title compound, C₂₂H₂₄N₄O₄, was prepared from propyl chloro­formate and 3,6‐di­phenyl‐1,2‐di­hydro‐s‐tetrazine. This reaction yields the title compound rather than di­propyl 3,6‐di­phenyl‐1,4‐di­hydro‐s‐tetrazine‐1,4‐di­carboxyl­ate. The 2,3‐di­aza­buta­diene group in the central six‐membered ring is not planar; the C=N double‐bond length is 1.285 (2) Å, and the average N—N single‐bond length is 1.401 (3) Å, indicating a lack of conjugation. The ring has a twist conformation, in which adjacent N atoms lie 0.3268 (17) Å from the plane of the ring. The mol­ecule has twofold crystallographic symmetry.     

Di­methyl 6‐methoxy‐4aβ‐methyl‐9‐oxo‐1,2,3,4,4a,9,10,10aβ‐octa­hydro­phenanthrene‐1,1‐di­carboxyl­ate

In the title tricyclic keto‐diester, C₂₀H₂₄O₆, a potential intermediate in the synthesis of bioactive podocarpic acid, the outer cyclo­hexane ring (in a chair conformation) is cis fused to the central cyclo­hexanone ring (in a half‐chair conformation). The conformational analysis of the compound, investigated by semi‐empirical quantum mechanical AM1 calculations, shows a good agreement with the X‐ray structure, except for the orientation of the methyl, methoxy­phenyl and methoxy­carbonyl substituents.     

A mixed‐valence manganese(III)–manganese(IV) di‐μ‐oxo complex, [(cyclam)MnO]2(ClO4)2(NO3)

The title dinuclear di‐μ‐oxo‐bis­[(1,4,8,11‐tetra­aza­cyclo­tetra­decane‐κ⁴N)­manganese(III,IV)] diperchlorate nitrate complex, [Mn₂O₂(C₁₀H₂₄N₄)₂](ClO₄)₂(NO₃) or [(cyclam)Mn­O]₂(ClO₄)₂(NO₃), was self‐assembled by the reaction of Mn²⁺ with 1,4,8,11‐tetra­aza­cyclo­tetra­decane in aqueous media. The structure of this compound consists of a centrosymmetric binuclear [(cyclam)MnO]³⁺ unit, two perchlorate anions and one nitrate anion. While the low‐temperature electron paramagnetic resonance spectra show a typical 16‐line signal for a di‐μ‐oxo Mn^III/Mn^IV dimer, the magnetic susceptibility studies also confirm a characteristic antiferromagnetic coupling between the electronic spins of the Mn^IV and Mn^III ions.     

2‐Meth­oxy‐4‐[(5‐oxo‐2‐phenyl‐4,5‐dihydro‐1,3‐oxazol‐4‐yl­idene)meth­yl]­phenyl 4‐methyl­benzene­sulfonate

Mol­ecules of the title compound, C₂₄H₁₉NO₆S, adopt the Z configuration and have a distorted tetra­hedral geometry around the S atom. The oxazolone, 2‐phenyl and methoxy­phenyl rings are approximately coplanar. The C atom between the methoxy­phenyl and oxazolone rings displays a distorted trigonal bonding geometry. Pairs of mol­ecules are linked into dimers through weak C—H⋯O hydrogen bonds.     

A second triclinic modification of 2′,6′‐di­methoxy­flavone

Crystals of a second triclinic modification of the title compound, 2‐(2,6‐di­methoxy­phenyl)‐4H‐1‐benzo­pyran‐4‐one, C₁₇H₁₄O₄, were grown from a hot cyclo­hexane solution. In the mol­ecule, the O—C—C—C torsion angle at the junction between the benzo­pyran and phenyl rings is 67.6 (3)°.     

Di‐μ‐chloro‐bis­{bis­[2,5‐bis­(4‐methoxy­phenyl)‐1,3,4‐oxadiazole‐κ2C2′,N]iridium(III)] dichloro­methane disolvate

In the title compound, [Ir₂(C₁₆H₁₃N₂O₃)₄Cl₂]·2CH₂Cl₂, the two Ir atoms, 3.7075 (6) Å apart, are bridged by two Cl atoms which straddle a twofold axis of rotation through the two Ir atoms. Each Ir centre resides in a distorted octa­hedral environment completed by two chelating 2,5‐bis­(4‐methoxy­phenyl)‐1,3,4‐oxadiazole ligands, with trans‐N—N and cis‐C—C dispositions. In the stacking structure, there are two types of hydrogen bonds, involving the meth­oxy substitutent, an N atom of the oxadiazole ring and the dichloro­methane solvent mol­ecules.     

2,9‐Bis(3‐nitrophenyl)‐1‐azaadamantan‐4‐one

The title compound, 2,9‐bis(3‐nitro­phenyl)‐1‐aza­tri­cyclo[3.3.1.1^3,7]­decan‐4‐one, C₂₁H₁₉N₃O₅, has a tricyclic structure. The torsion angles may be used to describe the relationship of the carbonyl group to the adjacent faces, whereby it is seen that the angles on the face of the aryl­piperidinone side [122.0 (3) and ?122.0 (3)°] are greater than those on the cyclo­hexanone side [?119.8 (4) and 119.9 (4)°]. Although these differences may explain a facial selectivity during nucleophilic addition to the carbonyl group, the presence of the aryl rings is probably also important.